Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Meridian Bioscience third-quarter net sales decrease 11% to $33.9 million

Net sales for the third quarter of fiscal 2010 were $33,857,000 as compared to $38,240,000 for the same period of the prior fiscal year, a decrease of 11%. Net earnings for the third quarter of fiscal 2010 were $6,424,000 or $0.16 per diluted share, both decreases of 24%, compared to the third quarter of fiscal 2009. (Net earnings include $673,000 in Bioline acquisition costs or $0.01 per diluted share.) Diluted common shares outstanding for fiscal 2010 and 2009 were 41,151,000 and 41,191,000, respectively.

20 Jul 2010

NanoViricides presents study results of nanoviricides anti-Ebola agents

NanoViricides, Inc. reports that the results of the evaluation of several of its nanoviricides anti-Ebola agents were presented July 17th at the Annual Meeting of the American Society for Virology, July 17-21, at Montana State University, Bozeman, MT. Dr. Corinne Scully delivered the presentation, which was entitled "Polymeric Micelle Nanomaterials as Antiviral Compounds For Ebola Virus Infection."

20 Jul 2010

Scientists develop new way to increase effectiveness of antiviral drugs

Scientists have developed a new way to target viruses which could increase the effectiveness of antiviral drugs.Instead of attacking the virus itself, the method developed at the University of Edinburgh alters the conditions which viruses need to survive and multiply.

20 Jul 2010

Ratio secures equity financing

Ratio, Inc. has secured equity financing from regional angel investors and angel networks. The groups participating in the round include Wisconsin Investment Partners, The Golden Angels Network, Stateline Angels, and Central Illinois Angels. The company is keeping the round of financing open for 120 days and actively pursuing further investment.

20 Jul 2010

Plea for Federal legislation to ban mercury in vaccines, prevent autism

Two papers in this week's neuroscience journal Acta Neurobiologiae Experimentalis point to vaccines and heavy metals including mercury as causes of the alarming rise in autism. The Centers for Disease Control now estimate autism to affect one in 110 children, up 40% from just a few years ago.

20 Jul 2010

Patients often receive inappropriate care when doctors fail to understand patient's situation: Study

Patients often receive inappropriate care when their doctors fail to take into account their individual circumstances, according to a new study by the University of Illinois at Chicago and the VA Center for Management of Complex Chronic Care.

20 Jul 2010

Phase 2 CUBICIN study for prosthetic joint infections meets primary endpoint

Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced that its Phase 2 safety study of CUBICIN (daptomycin for injection) in the treatment of prosthetic joint infections caused by certain Gram positive pathogens met its study objectives. This study was a first-of-its-kind randomized controlled Phase 2 trial studying anti-infective therapy in the setting of 2-stage surgery for the replacement of infected prosthetic hip or knee joints.

19 Jul 2010

Study evaluates immunization benefits of dissolving microneedles

A new vaccine-delivery patch based on hundreds of microscopic needles that dissolve into the skin could allow persons without medical training to painlessly administer vaccines - while providing improved immunization against diseases such as influenza.

19 Jul 2010

Pneumococcal conjugate vaccine appears to reduce pneumonia, serious complications in infants: Research

A pneumococcal conjugate vaccine introduced in the U.S. 10 years ago appears to reduce pneumonia and serious associated complications, such as blood infections, in the vaccine's target range, children less than a year old, according to new research.

19 Jul 2010

People needing non-emergent care can now turn to walk-in centers

For many, summer time means cook-outs, family hikes, and trips to the beach. However, while the good weather brings an increase in outdoor activities, for some it can also mean a trip to the local emergency room.

17 Jul 2010

BioRadar develops TransFMDV for Foot and Mouth Disease

BioRadar UK Ltd. predicted one year ago the current severe Foot and Mouth Disease (FMD) outbreaks after recording an increase of the Replikin Count (ref. 1) of the FMD Virus (FMDV) to its highest level in 52 years. Based on these findings, a new synthetic Replikins Trans-Strain FMD Vaccine, called TransFMDV(TM), has been developed and is now available. The announcement was made at the recent Biorbis Conference on Vaccine Production and Manufacturing in Amsterdam, the Netherlands. The conference was attended by major pharmaceutical company executives to examine how vaccine production could be accelerated in view of the problem last year of responding "too little, too late" to the H1N1 influenza pandemic.

17 Jul 2010

FDA can promote personalized medicine by identying gaps in laboratory operations: ACLA

The Food and Drug Administration can promote progress toward personalized medicine by approaching the oversight of laboratory developed tests (LDTs) in a focused, flexible, and balanced way according to the American Clinical Laboratory Association (ACLA). ACLA, which represents the nation's leading clinical laboratories, says that the factors supporting this approach include the growing role that such tests play in clinical decision making, especially in the area of new advanced diagnostics that derive from the mapping of the human genome and help fulfill the promise of personalized medicine.

17 Jul 2010

Also in Global Health News: WHO reacts to Amnesty's N. Korea report; Universal flu vaccine; Malaria-resistant mosquitoes

The WHO is questioning the validity of the findings of a recent Amnesty International report which highlighted the dire needs of North Korea's health system, "contradict[ing] the rosier picture given by WHO chief Margaret Chan after her April trip there," the Associated Press reports. Although WHO spokesman Paul Garwood "insisted he wasn't criticizing Amnesty's work … he said Thursday's report was anecdotal, with stories dating back to 2001," which "[h]e contrasted … with WHO's science-based approach" (7/16).

17 Jul 2010

Recent releases in Global Health

As part of a series in advance of AIDS 2010, the "Science Speaks" blog features an interview with U.S. Global AIDS Coordinator Eric Goosby "about his expectations for the conference, what was behind the Uganda problem with shortages of AIDS medicine, and whether The New York Times was right when it reported in May that the Ugandan drug shortfall was 'the first example … of how the war on AIDS is falling apart.'"

16 Jul 2010

Study finds unhappy families unhappy in two distinct ways

Contrary to Leo Tolstoy's famous observation that "happy families are all alike; every unhappy family is unhappy in its own way," a new psychology study confirms that unhappy families, in fact, are unhappy in two distinct ways. And these dual patterns of unhealthy family relationships lead to a host of specific difficulties for children during their early school years.

16 Jul 2010

Spanish scientists develop new parasite detection method to prevent Anisakidosis

A new method enables anisakids to be detected in any fish product, from a whole fish, fresh or frozen, to tinned fish and surimi. Developed by Spanish scientists, the system is based on molecular techniques and overcomes the limitations of traditional procedures.

16 Jul 2010

An overview of heart palpitations from Mayo Clinic

Almost everyone feels occasional heart palpitations -- a change in the heart's rhythm. Palpitations range from what feels like a skip, flip or bump in the heart's rhythm to a sustained, racing heartbeat.

16 Jul 2010

Hemispherx publishes report of Japanese government funded program to develop nasally delivered H5N1 vaccine

Hemispherx Biopharma, Inc. announced that it was publicizing the full technical (unedited) report in Japanese, prepared by Hideki Hasegawa, M.D. Ph.D., Director, Laboratory of Infectious Disease Pathology, National Institute of Infectious Disease (NIID, formerly Japan's National Institute of Health) and the certified English translation.

16 Jul 2010

IBM dedicates $100 million for global initiative to improve healthcare quality and costs

IBM today announced plans to enlist some of the company's leading scientists and technologists to help medical practitioners and insurance companies provide high-quality, evidence-based care to patients. As part of this initiative, IBM is collaborating with clinicians in medical institutions and hiring medical doctors to work alongside its researchers to develop new technologies, scientific advancements and business processes for healthcare and insurance providers.

15 Jul 2010

New drug launches for HCV in the Philippines to increase market earned revenues to $4.5 billion by 2017

Efforts to raise disease awareness in the Philippines have increased the number of cases and patient pool available for hepatitis C treatment. Screening and detection efforts by the Red Cross as well as growing awareness in the Philippines have been largely responsible for the rise in the number of diagnosed cases. These campaigns have encouraged people, mostly from the urban areas, to opt for physical examinations that enable the detection of hepatitis C.

15 Jul 2010

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Meridian Bioscience third-quarter net sales decrease 11% to $33.9 million

NanoViricides presents study results of nanoviricides anti-Ebola agents

Scientists develop new way to increase effectiveness of antiviral drugs

Ratio secures equity financing

Plea for Federal legislation to ban mercury in vaccines, prevent autism

Patients often receive inappropriate care when doctors fail to understand patient's situation: Study

Phase 2 CUBICIN study for prosthetic joint infections meets primary endpoint

Study evaluates immunization benefits of dissolving microneedles

Pneumococcal conjugate vaccine appears to reduce pneumonia, serious complications in infants: Research

People needing non-emergent care can now turn to walk-in centers

BioRadar develops TransFMDV for Foot and Mouth Disease

FDA can promote personalized medicine by identying gaps in laboratory operations: ACLA

Also in Global Health News: WHO reacts to Amnesty's N. Korea report; Universal flu vaccine; Malaria-resistant mosquitoes

Recent releases in Global Health

Study finds unhappy families unhappy in two distinct ways

Spanish scientists develop new parasite detection method to prevent Anisakidosis

An overview of heart palpitations from Mayo Clinic

Hemispherx publishes report of Japanese government funded program to develop nasally delivered H5N1 vaccine

IBM dedicates $100 million for global initiative to improve healthcare quality and costs

New drug launches for HCV in the Philippines to increase market earned revenues to $4.5 billion by 2017

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in